Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment of COVID-19
Clinical trial NCT04603651 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT04603651
- Sponsor
- Eli Lilly and Company
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.